Tenzing Acquisition Corp.

Status: Deal Closed
U=S+W W=S@11.5
IPO Proceeds, $M $63.25M
IPO Date Aug 21, 2018
CEO Rahul Nayar
Left Lead Maxim
IPO Cash in Trust 100.0%
SPAC Tenor 18+3+2+1+1+3
IPO Sector General

India

IPO Geography Asia
Target Company Reviva Pharma
Deal Announced Jul 21, 2020
Deal Size, $M $85.80M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Dec 8, 2020
Amendment Vote TBD
Closing Date Dec 14, 2020
Formerly TZAC RVPH RVPHW

Sign up for Free Trial

No credit card required

Sign in for more on Tenzing Acquisition Corp.:

  • Structure and cap table
  • 7 directors & officers
  • 43 filings and events
  • 1 underwriters
  • 1 deal advisors
  • 3 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Parag Saxena 63 Chairman of the Board
Rahul Nayar 49 CEO & Director
Gonzalo Cordova 63 CFO
Atanuu Agarrwal 29 Vice President
William I. Campbell 74 Director
Nina Shapiro 69 Director
Vikas Thapar 69 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Maxim BR 5,500,000 units
5,500,000 units
Up-Front UW fee 2.25 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 43 filings.

Shareholders

Sign in to view shareholders 13F filing data.